A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
Clinical trial NCT02330991 · COMPLETED
Trial details
- NCT number
- NCT02330991
- Sponsor
- Beijing Sanbo Brain Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2020-03-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.